Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The importance of genomics-based stratification in multiple myeloma

Monique Minnema • 11 Jun 2022
EHA 2022
Multiple Myeloma

Monique Minnema, MD, PhD, University Medical Center Utrecht, Utrecht, Netherlands, briefly discusses the importance of genomics-based stratification in multiple myeloma and how this is applied in the clinic. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Monique Minnema

1:20
A comparison of bispecific antibodies emerging in multiple myeloma
Monique Minnema • 11 Jun 2022
1:18
Updates from the MonumenTAL-1 trial
Monique Minnema • 11 Jun 2022
1:37
Patient education in CAR T-cell therapy
Monique Minnema • 20 Mar 2019
1:58
The logistical challenges of CAR T-cell therapy
Monique Minnema • 20 Mar 2019

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals